University of Alabama at Birmingham

Essais liés32clinical trials

VilleBirminghamlocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05104983

Ouvrir le site du centre

Essais cliniques associés

Molécule	Indication / population	Phase	NCT	Titre	Statut
Evolocumab	Maladie coronarienne	Phase 4	NCT05284747	EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction	ACTIVE_NOT_RECRUITING
XEN1101	Épilepsie	Phase 2	NCT03796962	X-TOLE — A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy	ACTIVE_NOT_RECRUITING
buntanetap/posiphen	Parkinson	Phase 2/3	NCT07284784	A Study of Buntanetap in Participants With PD	RECRUITING
IV acetaminophen	Maladie coronarienne	Phase 3	NCT04093219	PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients	COMPLETED
Lorcaserin	Épilepsie	À vérifier	NCT04457687	Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies	NO_LONGER_AVAILABLE
Empagliflozin	Maladie rénale chronique	Phase 3	NCT07107945	A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)	ACTIVE_NOT_RECRUITING
Surgical management	Accident vasculaire cérébral	Non applicable	NCT06870812	REACH — Rapid Evacuation and Access of Cerebral Hemorrhage Trial	RECRUITING
WATCHMAN FLX LAAC Device	Accident vasculaire cérébral	Non applicable	NCT04394546	CHAMPION-AF Clinical Trial	ACTIVE_NOT_RECRUITING
Sirolimus	Épilepsie	Phase 2	NCT05104983	TSC-STEPS — Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study	ACTIVE_NOT_RECRUITING
RNS System	Épilepsie	Phase 2	NCT05339126	RNS System LGS Feasibility Study	ACTIVE_NOT_RECRUITING
Prasinezumab	Parkinson	Phase 2	NCT04777331	PADOVA — A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease	ACTIVE_NOT_RECRUITING
Intravenously administered pooled human immunoglobulin (IVIG)	Myopathies	Phase 2	NCT06599697	The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy	RECRUITING
MIGHT-SLE — Home-Based High-Intensity Interval Training in Systemic Lupus Erythematosus	Lupus	Non applicable	NCT07716462	MIGHT-SLE — Home-Based High-Intensity Interval Training in Systemic Lupus Erythematosus	NOT_YET_RECRUITING
Solanezumab	Alzheimer	Phase 3	NCT02008357	A4 — Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss	COMPLETED
AIDP — Automated Imaging Differentiation of Parkinsonism	Parkinson	À vérifier	NCT05913687	AIDP — Automated Imaging Differentiation of Parkinsonism	ACTIVE_NOT_RECRUITING
Trans-auricular Vagus Nerve Stimulation: High Intensity	Myopathies	Non applicable	NCT07523113	ME/CFS Brain Fog: Cognitive Rehabilitation Trial	RECRUITING
Neuraceq	Alzheimer	À vérifier	NCT05617014	ADNI4 — Alzheimer's Disease Neuroimaging Initiative 4	ENROLLING_BY_INVITATION
AAV9-hSyn1-miGRIK2	Épilepsie	Phase 1/2	NCT06063850	GenTLE — AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy	RECRUITING
Trontinemab	Alzheimer	Phase 3	NCT07169578	TRONTIER 1 — A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease	ACTIVE_NOT_RECRUITING
Prasinezumab	Parkinson	Phase 3	NCT07174310	PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease	RECRUITING
TREAT-MS — Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial	SEP	Non applicable	NCT03500328	TREAT-MS — Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial	ACTIVE_NOT_RECRUITING
The FamilyStrong Pilot Randomized Trial	Cancer	Non applicable	NCT07761988	The FamilyStrong Pilot Randomized Trial	NOT_YET_RECRUITING
Permanent Epidural Spinal Cord Stimulation	Hypertension	Non applicable	NCT05556902	Therapeutic Mechanisms of Epidural Spinal Cord Stimulation	RECRUITING
Clemizole HCl	Épilepsie	Phase 3	NCT04462770	ARGUS — A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome	RECRUITING
RAP-219	Épilepsie	Phase 3	NCT07563881	FOCUS 1 — Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1	RECRUITING
CT1812	Alzheimer	Phase 2	NCT05531656	A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease	ACTIVE_NOT_RECRUITING
The Paradise® Renal Denervation Ultrasound System	Hypertension	Non applicable	NCT02649426	RADIANCE-HTN — A Study of the ReCor Medical Paradise System in Clinical Hypertension	ACTIVE_NOT_RECRUITING
ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	Alzheimer	À vérifier	NCT01078636	ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	COMPLETED
Passive Versus Active Music Therapy Parkinson's Disease	Parkinson	NA	NCT07661524	Passive Versus Active Music Therapy Parkinson's Disease	NOT_YET_RECRUITING
CVN424 75 mg	Parkinson	Phase 3	NCT06553027	To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications	ACTIVE_NOT_RECRUITING
eculizumab	Myasthénie	Phase 2	NCT00727194	Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis	TERMINATED
Low-Dose Naltrexone, 1.5mg	Myopathies	Phase 2	NCT07285473	Low-Dose Naltrexone For ME/CFS: Dose-Finding	NOT_YET_RECRUITING